PARTNER NEWS:Tue, Apr 23, 11:16 AM, Zacks
GSK Gears Up for Q1 Earnings: Here's What to Expect
We expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.
Fri, Apr 19, 4:15 PM, Zacks
Why the Market Dipped But GSK (GSK) Gained Today
In the latest trading session, GSK (GSK) closed at $39.75, marking a +1.22% move from the previous day.